लोड हो रहा है...

Retained platinum uptake and indifference to p53 status make novel transplatinum agents active in platinum-resistant cells compared to cisplatin and oxaliplatin

Despite the clinical success of platinum-containing drugs in the treatment of solid tumors, acquired resistance remains a major obstacle. We previously identified a group of novel transplanaramine or transplatinum compounds based on distinct activity profiles in the NCI-60 panel. In the present stud...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Murphy, Robert F., Komlodi-Pasztor, Edina, Robey, Rob, Balis, Frank M., Farrell, Nicholas P., Fojo, Tito
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Landes Bioscience 2012
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3679288/
https://ncbi.nlm.nih.gov/pubmed/22333583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cc.11.5.19447
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!